Allergan’s bimatoprost implant (Durysta) is now the first approved intracameral, sustained-release therapy for lowering IOP in patients with open-angle glaucoma or ocular hypertension. Source: AAO
This prospective, observational case series evaluated the severity of macular vascular changes in children with sickle cell disease. Source: AAO
The authors analyzed the proportion of females presenting at 9 major ophthalmology conferences over a 3-year period. Source: AAO
This systematic review evaluated evidence relating to 3 different autologous limbal stem cell transplantation (LSCT) techniques. Source: AAO
This prospective clinical trial compared the long-term safety and efficacy of amniotic membrane-umbilical cord and pericardium patch grafts for reducing glaucoma shunt tube exposure. Source: AAO
This week, surgeons discover a Phillips-head screw buried under a woman’s retina, a novel implant bypasses the eyes to restore vision and researchers share updates on a stem cell and gene therapies for retinitis pigmentosa. Source: AAO
This study evaluated adjuvant corneal crosslinking (CXL) for treatment of filamentous fungal keratitis. Source: AAO
Novartis has launched a safety review of their new anti-VEGF agent brolucizumab (Beovu) following reports of possible unintended side effects after the drug was approved last October. Source: AAO
This paper focuses on corneal and glaucoma outcomes among patients with Peters anomaly. Source: AAO
The authors describe an evolutionary algorithm that designs biological machines—an approach that could one day possibly be used to safely deliver drugs or repair damaged tissue inside the human body. Source: AAO